Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2025-12-25 @ 2:16 AM
NCT ID:
NCT03037060
Eligibility Criteria:
Inclusion Criteria:
* Subjects will meet diagnostic criteria for alcohol use disorder (mild through severe).
* Willing to abstain from drugs and alcohol prior to study visits
* A negative urine screen for illicit psychoactive drug use
* Willing and capable to provide written informed consent
* Willing to participate in cue exposure and intravenous alcohol administration sessions
* Male and female adults (at least 19 years old)
Exclusion Criteria:
* DSM diagnosis of drug dependence other than alcohol
* Any severe Axis I disorder aside from alcohol use disorder
* Any medical condition requiring immediate investigation
* History of seizures, past or current neurological illness or serious head trauma
* Suicidal ideation
* Pregnancy tested by urine or blood screen or lactation
* Current past or anticipated exposure to radiation exceeding permissible limits as set by the CAMH PET Centre
* Metal implants or paramagnetic objects within the body which may interfere with the MRI
* Claustrophobia or a history of panic attacks
* Any other problem that, in the investigators' opinion, would preclude participation in trial (i.e., complicated withdrawal).
* Currently seeking treatment or attempting to reduce/quit drinking
* History of negative responses to venipuncture procedures (e.g., fainting/vasovagal response)
* Medications or medical disorders for which alcohol consumption is contraindicated
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT03037060
Study Brief:
Protocol Section:
NCT03037060